Oropharyngeal Dysphagia clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia

    open to eligible people ages 18 years and up

    The primary objective of this double-blind, randomized, placebo-controlled, multicenter clinical trial is to evaluate the safety of AMDC-GIR during the 24 months following 2 consecutive treatments of tongue dysphagia in male and female patients who have undergone surgery and/or chemo- and/or radiotherapy for squamous cell cancer of the oropharynx.

    San Francisco, California and other locations

Our lead scientists for Oropharyngeal Dysphagia research studies include .

Last updated: